CK5 Primary Antibody
|Aliases||KRT5; K5; DDD; EBS2; KRT5A|
|Formulation||Purified antibody in PBS with 0.05% sodium azide|
|Immunogen||Purified recombinant fragment of human CK5 (AA: 316-590) expressed in E. Coli.|
|Shipping Information||This product will ship in a box containing blue ice at a temperature of 4°C. Learn More|
|IHC_P(Immunohistochemistry)||1/200 - 1/1000|
|WB (Western Blot)||1/500 - 1/2000|
Contact us to order
Figure 1: Western blot analysis using CK5 mAb against human CK5 recombinant protein. (Expected MW is 47.8 kDa)
Figure 2: Western blot analysis using CK5 mouse mAb against A431 cell lysate.
Figure 3: Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using CK5 mouse mAb with DAB staining.
Figure 4: Immunohistochemical analysis of paraffin-embedded esophagus cancer tissues using CK5 mouse mAb with DAB staining.
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
|Description||The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Mutations in these genes have been associated with a complex of diseases termed epidermolysis bullosa simplex. The type II cytokeratins are clustered in a region of chromosome 12q12-q13. |
|References (references)||1. Mol Biol Cell. 2011 Nov;22(21):4068-78. |
2. Am J Surg Pathol. 2009 Nov;33(11):1615-23.